SCHEMBL6152948

SCHEMBL6152948

C=CCOC(=O)Oc1ccc(Oc2ccc(OC(=O)OCC=C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 2/20 0.40
ELANE P08246 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP14 P50281 2/20 0.40
MMP8 P22894 1/20 0.40
GAA P10253 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
RAB9A P51151 2/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
THRB P10828 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10870487 0.94 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10SMN1; SMN2
SCHEMBL9717273 0.87 ALDH1A1 (0.48) CYP3A4ALDH1A1ELANETSHRHSD17B10
SCHEMBL9700576 0.86 CYP3A4 (0.43) CYP3A4ALDH1A1TSHRHSD17B10GAA
SCHEMBL6153149 0.86 SNCA (0.51) CYP3A4ALDH1A1TSHRHSD17B10GAA
SCHEMBL1598844 0.86 LMNA (0.48) CYP3A4ALDH1A1TSHRHSD17B10GAA
SCHEMBL6152601 0.86 ELANE (0.49) CYP3A4ALDH1A1ELANETSHRHSD17B10
SCHEMBL6151946 0.86 ELANE (0.46) CYP3A4ALDH1A1ELANETSHRHSD17B10
SCHEMBL9174753 0.86 CYP3A4 (0.43) CYP3A4ALDH1A1TSHRHSD17B10SMN1; SMN2
SCHEMBL5605875 0.86 KMT2A (0.48) CYP3A4ALDH1A1ELANETSHRHSD17B10
SCHEMBL545547 0.85 CYP3A4 (0.55) CYP3A4ALDH1A1TSHRHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497288-B1 NOVEL ESTER HYDROXY-SUBSTITUTED NITROGEN HETEROCYCLES AS ANTAGONISTS OF THE MUSCARINIC M3 RECEPTOR, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2005-12-28 EP disclosed
EP-1497288-A1 NOVEL ESTER HYDROXY-SUBSTITUTED NITROGEN HETEROCYCLES AS ANTAGONISTS OF THE MUSCARINIC M3 RECEPTOR, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2005-01-19 EP disclosed
WO-2003087096-A1 NOVEL ESTER HYDROXY-SUBSTITUTED NITROGEN HETEROCYCLES AS ANTAGONISTS OF THE MUSCARINIC M3 RECEPTOR, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-10-23 WO disclosed
EP-1196466-A1 POLYMERIZABLE COMPOSITION OF ALIPHATIC POLYOL (ALLYL CARBONATE) PPG Industries Ohio, Inc. (US) 2002-04-17 EP disclosed
WO-2000078832-A1 POLYMERIZABLE COMPOSITION OF ALIPHATIC POLYOL (ALLYL CARBONATE) PPG INDUSTRIES OHIO, INC. (US) 2000-12-28 WO disclosed